FDA Inspection
Catalent Pharma Solutions, LLCCatalent Pharma Solutions, LLC – FDA Inspection, Nov 21, 2025
Record Details
This FDA Inspection record concerns Catalent Pharma Solutions, LLC, with an inspection on November 21, 2025, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · ff8fc52d-bf9c-42ed-b3c5-9a5ec1212111
Inspection Facts
- Inspection number
- 1285382
- FDA center
- Human Drugs
Other FDA inspections of Catalent Pharma Solutions, LLC
12| Date | Classification | Office | Project area |
|---|---|---|---|
| February 1, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 13, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 19, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 21, 2017 | Not classified | New Jersey District Office | |
| January 17, 2017 | Not classified | New Jersey District Office |
Other documents for Catalent Pharma Solutions, LLC
- FDA Inspection 1199635 - 2023-02-01
- FDA Inspection 1063006 - 2018-07-13
- FDA Inspection 1039238 - 2018-01-19
- FDA Inspection 1024255 - 2017-08-21
- FDA Inspection 996931 - 2017-01-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.